WPC  -G b=ËR9yD9"R2\bͩo.L:,.< nFg+u=*Y9:7le[\Tp _aaW8p$CtL/jo _u0qPWEe^=ik-Io~x*zU\?RΓꖱ*8oĒ wʌ)֣18(d !ÓD/톥2lĮ|=b/YDw~?_˧]G,Իk(:cq34m8{]35bJ:#5]n4W eW|݌" (#(# Ќ  "3"  3n2#  18  .3  0    Completeworkontimeandmeetdeadlinesforassignments.3n݌l#!(#(# Ќ  "3"  3q2#  19  .3  0    Maintaintheconfidentialityofpatientinformation..3q݌X$"(#(# Ќ  "3"  3p2#  20  .3  0    FollowallsafetyguidelinesoftheMLTprogramandclinicalsite.3p݌D% #(#(# Ќ  "3"  3|2#  21  .3  0    Conformtotheclinicaldresscode.3|݌0&!$(#(# Ќ  "3"  3i2#  22  .3  0    Conformtothe_ASCLS_ԀCodeofEthics.3i݌'l"%(#(# Ќ   +'* ЇSPECIMENHANDLINGANDPROCESSING    (#33"3"  3N2#  1  .3  0    Followingdepartmentalprotocol,demonstratesafeworkpracticesby:3N{݌(#(# Ќ  ";"  ;[ 0  2#  a  .3  0` (#(#  Wearingpersonalprotectiveequipment(_PPE_)asrequired.;[ ݌t` (#` (# Ќ  ";"  ;!0  2#  b  .3  0` (#(#  Handlinganddisposingofcontaminatedmaterialsaccordingtostandard ` precautions.;!!݌L ` (#` (# Ќ  ";"  ;"0  2#  c  .3  0` (#(#  Handlingchemicalsaccordingtosafetyprocedures.;"#݌8 ` (#` (# Ќ  "3"  3#2#  2  .3  0    Explaintheimportanceofpropercollectionandtransportofspecimens.3#$݌$ t(#(# Ќ  "3"  3$2#  3  .3  0    Listcriteriaforevaluatingspecimenqualityandcorrectiveactionstoresolveproblems.3$ %݌ `(#(# Ќ  "3"  3&2#  4  .3  0    Evaluatespecimensuitabilityforanalysisusingestablishedcriteriaintheprocedure  L  manual.3&B&݌ 8 (#(# Ќ  "3"  3P'2#  5  .3  0    Preparespecimenforanalysisbyprocessingaccordingtodepartmental_protocols._3P'}'݌$ (#(# Ќ  QUALITYASSURANCEANDQUALITYCONTROL     ! ! (#33"3"  3t)2#  1  .3  0    Performkitqualitycontrolaccordingtothemanufacturersinstructions.THISSHOULD   BEPERFORMEDATTHESAMETIMEASPATIENTTESTING.3t))݌t(#(# Ќ  "3"  3*2#  2  .3  0    Performordiscusscorrectiveactionneededtobetakenifqualitycontrolvaluesarenot ` withinestablishedlimits.3* +݌L(#(# Ќ  "3"  3-,2#  3  .3  0    Reportorrecordqualitycontrolresultsaccordingtothestandardoperatingproceduresof 8 thelaboratorywith95%accuracy.3-,Z,݌$t(#(# Ќ  "3"  3-2#  4  .3  0    Listsubstancesthatwillcausefalsenegativeandfalsepositiveresultsintheprocedure ` beingperformed.3--݌L(#(# Ќ  "3"  3.2#  5  .3  0    Statetheconfidentialitypolicyofthefacilityduringtestingprocedureandreportingin 8 accordancewith_HIPAA_Ԁguidelines.3..݌$(#(# Ќ  "3"  3G02#  6  .3  0    Observebasiccomputerapplicationswhererelevant.3G0t0݌(#(# Ќ  TECHNICALPROCEDURE(PSYCHOMOTORANDCOGNITIVE)   ! ! (#33"3"  3322#  1  .3  0    Reviewthedepartmentalproceduremanualorreagentpackageinserts.332`2݌p(#(# Ќ  "3"  3@32#  2  .3  0    Performserologicaltestingonassignedspecimenswith95%accuracyaccordingtothe \  following:3@3m3݌H!(#(# Ќ  ";"  ;|40  2#  a  .3  0` (#(#  Evaluatesuitabilityofsample.;|44݌4" ` (#` (# Ќ  ";"  ;x50  2#  b  .3  0` (#(#  Reviewprincipleandlimitationsoftheprocedure.;x55݌ #p!` (#` (# Ќ  ";"  ;60  2#  c  .3  0` (#(#  CarefullyreviewtheinstructionsPRIORtoperformingthetest.;66݌ $\"` (#` (# Ќ  ";"  ;70  2#  d  .3  0` (#(#  Determineadditionalsuppliesrequiredtoperformtheprocedure.;77݌$H #` (#` (# Ќ  ";"  ;80  2#  e  .3  0` (#(#  Organizesample,reagentsandsuppliesinamannertoperformtheprocedure %4!$ withinappropriatetimelimits.;88݌& "%` (#` (# Ќ  ";"  ;:0  2#  f  .3  0` (#(#  Interpretthecontrolsanddeterminetheirvalidity.;:I:݌' #&` (#` (# Ќ  ";"  ;-;0  2#  g  .3  0` (#(#  Interpretthepatientresults.;-;Z;݌(#'` (#` (# Ќ  ";"  ;(<0  2#  h  .3  0` (#(#  Bringaberrantresultstotheattentionoftheinstructor.;(<U<݌)$(` (#` (# Ќ  ";"  ;?=0  2#  i  .3  0` (#(#  Reporttheresultsintheproperformatasstatedinthepackageinsert.;?=l=݌*%)` (#` (# Ќ   l+&*    COGNITIVEOBJECTIVES   X@XXX@ (#33 "3"  3T?2#  1  .3  0    Correctlyperformwith95%accuracyavarietyofserologicaltestsby:3T??݌(#(# Ќ  ";"  ;c@0  2#  a  .3  0` (#(#  Evaluatingpatientsampleforsuitability.;c@@݌t` (#` (# Ќ  ";"  ;jA0  2#  b  .3  0` (#(#  Followingthereagentpackageinserttocorrectlyperformthetest.;jAA݌`` (#` (# Ќ  ";"  ;B0  2#  c  .3  0` (#(#  Gatherappropriatesuppliesasneededforthetestrequirements.;BB݌L ` (#` (# Ќ  ";"  ;C0  2#  d  .3  0` (#(#  Performthetestinatimelyfashionbyutilizingappropriateorganizationalskills.;CC݌8 ` (#` (# Ќ  ";"  ;D0  2#  e  .3  0` (#(#  Accuratelyanalyzeandinterprettheresultofthetest.;DE݌$ t` (#` (# Ќ  ";"  ;E0  2#  f  .3  0` (#(#  Evaluatetheresultsofcontrolsforvalidityoftestresults.;EF݌ `` (#` (# Ќ  ";"  ;G0  2#  g  .3  0` (#(#  Accuratelyrecordtheresult.;G5G݌ L ` (#` (# Ќ  ";"  ;H0  2#  h  .3  0` (#(#  Accuratelydocumenttheinformationneededforthekitused.;H/H݌ 8 ` (#` (# Ќ  ";"  ;I0  2#  i  .3  0` (#(#  Maintainaneatandorderlyworkstation.;IHI݌$ ` (#` (# Ќ  "3 "  3!J2#  2  .3  0    Brieflydefine,compareandcontrastactiveandpassiveimmunity.3!JNJ݌ (#(# Ќ  "3"  3+K2#  3  .3  0    Statethepurposeforperforminganantibodytitration.3+KXK݌ (#(# Ќ  "3"  3+L2#  4  .3  0    Giventhecontentsoftube1inaserialdilutioncalculatethetiterofeachtube.3+LXL݌ (#(# Ќ  "3"  3GM2#  5  .3  0    Contrastprimaryandsecondary(anamnestic)immuneresponsesastolengthoflatent   phase,speedofantibodyproduction,andgeneralclassofantibodyproduced.#X@XXX@>#X@XXX@3GMtM݌p(#(# Ќ  "3"  3O2#  6  .3  0    Describe,indetail,thestructureofasinglebasicantibodymolecule.3O5O݌\(#(# Ќ  "3"  3P2#  7  .3  0    Statethetwotypesoflightchainsinanantibodymolecule.3PEP݌H(#(# Ќ  "3"  3Q2#  8  .3  0    Foreachofthefollowingimmunoglobulinstatethestructure,whereitisfound,function, 4 abilitytobindcomplementandabilitytocrosstheplacenta.3QJQ݌ p(#(# Ќ  ";"  ;R0  2#  a  .3  0` (#(#  _IgM_;RR݌ \` (#` (# Ќ  ";"  ;S0  2#  b  .3  0` (#(#  _IgG_#X@XXX@N#X@XXX@;SS݌H` (#` (# Ќ    2 #  c  .3  0 ` _IgA_#X@XXX@rT#X@XXX@4` (#` (#   2 #  d  .3  0 ` _IgA_#X@XXX@sU#X@XXX@ ` (#` (#   2 #  e  .3  0 ` _IgD_#X@XXX@PV#X@XXX@ ` (#` (# "3"  3lW2#  9  .3  0    Describetheprimaryandsecondaryimmuneresponsesincludinglengthoftimefor  antibodyproductionandantibodyclassinvolved.3lWW݌(#(# Ќ  "3 "  3X2#  10  .3  0    Statethetermusedtodescribeanantibodywhichbindscomplementandcausesredcell l lysis.3XX݌X (#(# Ќ  "3 "  3Z2#  11  .3  0    Listfourfactorswhichinfluenceantigenantibodyreactions#X@XXX@-W#X@XXX@3Z2Z݌D!(#(# Ќ  "3 "  3M[2#  12  .3  0    Compareandcontrast_hapten_Ԁwithantigen.#X@XXX@Z#X@XXX@3M[z[݌0" (#(# Ќ  "3 "  3\2#  13  .3  0    Statethenumberedorderinwhichthecomplementcomponentsareactivatedinthe #l! classicalpathway,alternatepathwayandlectinpathways.#X@XXX@@\#X@XXX@3\\݌$X"(#(# Ќ  "3 "  3M^2#  14  .3  0    Compareagglutinationwithhemagglutination.#X@XXX@]#X@XXX@3M^z^݌$D #(#(# Ќ  "3"  3_2#  15  .3  0    Brieflydescribethefourreactioncombinationsthatoccuringels.#X@XXX@#_#X@XXX@3__݌%0!$(#(# Ќ  "3"  3`2#  16  .3  0    Describeradialimmunodiffusion(RID).Includewhatismixedintheagar,andwhatis &"% being_quantitated_Ԁandhow.#X@XXX@r`#X@XXX@3`a݌'#&(#(# Ќ  "3"  3b2#  17  .3  0    CompareandcontrastRIDand_Ouchterlony_Ԁgeldiffusion.#X@XXX@"b#X@XXX@3bb݌(#'(#(# Ќ  "3"  3c2#  18  .3  0    Statethethreeprincipleofreactionsmaybeobservedin_Ouchterlony_Ԁgeldiffusion#X@XXX@c#X@XXX@.3cd݌)$((#(# Ќ  "3"  3ne2#  19  .3  0    Comparetheterms competitiveand noncompetitiveastheyrelateto_immunoassays_.3nee݌|*%)(#(# Ќ  "3"  3f2#  20  .3  0    Comparetheterms homogeneousand heterogeneousastheapplyto_immunoassays_.#X@XXX@ e#X@XXX@3ff݌h+&*(#(# Ќ  "3"  3Ah2#  21  .3  0    #X@XXX@g#X@XXX@State#X@XXX@h#X@XXX@Ԁthepathogenicorganismresponsibleforhumansyphilis.#X@XXX@2i#3Ahnh݌(#(# Ќ  "3"  3i2#  22  .3  0    X@XXX@Statethemethodoftransmissionofhumansyphilis.#X@XXX@vj#3ij݌(#(# Ќ  "3"  3.k2#  23  .3  0    X@XXX@Describethesigns,symptomsandresultsofserologictestsforeachstageofsyphilis.#X@XXX@k#3.k[k݌(#(# Ќ  "3"  3l2#  24  .3  0    X@XXX@Define reaginasitrelatestosyphilis#X@XXX@m#.3ll݌t(#(# Ќ  "3"  3m2#  25  .3  0    X@XXX@Statethetwomostcommonlyusedreagintestsusedasscreeningtestsforsyphilis.#X@XXX@Un#3mm݌`(#(# Ќ  "3"  3-o2#  26  .3  0    X@XXX@Definebiologicfalsepositiveasitrelatestosyphilistesting.#X@XXX@o#3-oZo݌L (#(# Ќ  "3"  3zp2#  27  .3  0    X@XXX@Listfour(4)causesoffalsenegativesinthe_VDRL_Ԁand_RPR_Ԁtest.#X@XXX@q#3zpp݌8 (#(# Ќ  "3"  3r2#  28  .3  0    X@XXX@Compareandcontrastthe_VDRL_Ԁand_RPR_Ԁtestsastothemakeupoftheantigen,speedof $ t rotator,timeofrotationoftestandhowresultsareobserved.#X@XXX@r#3r4r݌ `(#(# Ќ  "3"  3s2#  29  .3  0    X@XXX@Statetheexpectedresultsforthefollowing_RPR_ԀQualityControlchecks#X@XXX@t#X@XXX@Ԁfor:needle  L  delivery,rotator_RPMs_,controlsandroomtemperatureandtheactiontotakeif  8  acceptableresultsarenotobtained.#X@XXX@-u#3s*t݌$ (#(# Ќ  "3"  3{v2#  30  .3  0    X@XXX@Listthetwomostcommonlyperformedsyphilistestswhichareclassifiedas reagin   tests.#X@XXX@w#3{vv݌ (#(# Ќ  "3"  3w2#  31  .3  0    X@XXX@ListfourspecificTreponmenaltestswhichmaybeperformedwhenapositivereagintest   isobtained.#X@XXX@x#3w*x݌ (#(# Ќ  "3"  3y2#  32  .3  0    X@XXX@Statethechallengesfortestinginfantsforsyphilis.#X@XXX@z#3yy݌p(#(# Ќ  "3 "  3z2#  33  .3  0    X@XXX@StatethesyphilisscreeningtesttoperformonaCSFsample.#X@XXX@J{#3zz݌\(#(# Ќ  "3!"  3 |2#  34  .3  0    X@XXX@DescribeCreactiveproteinincludingthesignificanceofelevatedamounts.3 |9|݌H(#(# Ќ  "3""  3@}2#  35  .3  0    #X@XXX@|#X@XXX@Statetheprincipleofthe_CRP_Ԁlatexagglutinationtest.#X@XXX@}#3@}m}݌4(#(# Ќ  "3#"  3~2#  36  .3  0    X@XXX@Compareandcontrastthe_CRP_ԀandESRinregardsto:howtestresultsareaffectedbythe  p following:serumproteinconcentration,anemia,duringinflammationandafter  \ inflammation.#X@XXX@N#3~~݌H(#(# Ќ  "3$"  3π2#  37  .3  0    X@XXX@Statethecausativeagentofprimaryatypicalpneumonia.#X@XXX@V#3π݌4(#(# Ќ  "3%"  32#  38  .3  0    X@XXX@Statetheprincipleofthecoldagglutinintestincludingthespecificityoftheantibody   involved.#X@XXX@#3@݌ (#(# Ќ  "3&"  32#  39  .3  0    X@XXX@Foraserialdilutionstatetheresultwhichwouldindicateaclinicallysignificantrisein  titerintwosamplescollectedoneweekapart.3Ã݌(#(# Ќ  "3'"  32#  40  .3  0    #X@XXX@#X@XXX@Inthecoldagglutinintiterstatetheexpectedresultsofthecellcontrolandtheaction  whichmustbetakeniftheexpectedresultisnotobtained.#X@XXX@ȅ#3K݌l(#(# Ќ  "3("  32#  41  .3  0    X@XXX@Statethenameofthechronicinflammatorydiseasewhichprimarilyaffectsthejointsand X  periarticulartissues#X@XXX@~#X@XXX@.#X@XXX@C#3$݌D!(#(# Ќ  "3)"  3Ɉ2#  42  .3  0    X@XXX@Definerheumatoidfactorandthespecificityofthissubstance.#X@XXX@P#3Ɉ݌0" (#(# Ќ  "3*"  32#  43  .3  0    X@XXX@Statetheprincipleofthelatexagglutinationtestfortrheumatoidarthritis#X@XXX@#X@XXX@.#X@XXX@*#3A݌#l!(#(# Ќ  "3+"  32#  44  .3  0    X@XXX@Statetheorganismresponsiblefortheconditionknownas Strepthroat(genusand $X" species)#X@XXX@7#X@XXX@.#X@XXX@#3݋݌$D #(#(# Ќ  "3,"  3u2#  45  .3  0    X@XXX@Listtwosequellawhichmayoccurifastrepthroatisleftuntreated.#X@XXX@#3u݌%0!$(#(# Ќ  "3-"  3Ȏ2#  46  .3  0    X@XXX@Listthetermusedfortheskininfectioncausedbystrep.#X@XXX@O#3Ȏ݌&"%(#(# Ќ  "3."  32#  47  .3  0    X@XXX@Listfive_exoantigens_ԀwhichareproducedbyStrep.#X@XXX@#3;݌'#&(#(# Ќ  "3/"  3m2#  48  .3  0    X@XXX@ListfiveantibodiesproducedinresponsetoaStrepinfectionwhicharemostusefulfor (#' laboratorytesting.#X@XXX@#X@XXX@3m݌)$((#(# Ќ  "30"  32#  49  .3  0    #X@XXX@#X@XXX@Statetheprincipleofthe_Streptozyme_Ԁtest.#X@XXX@“#3E݌|*%)(#(# Ќ  "31"  32#  50  .3  0    X@XXX@Statethecausativeagentofinfectiousmononucleosis#X@XXX@#X@XXX@.#X@XXX@#3݌h+&*(#(# Ќ  "32"  32#  51  .3  0    X@XXX@Brieflylistthesymptomsofaninfectiousmononucleosisinfection.#X@XXX@#3D݌(#(# Ќ  "33"  3g2#  52  .3  0    X@XXX@Describethehematologicalpictureseenonaperipheralsmearininfectious  mononucleosisincludingthespecifictypeofwhitecellwhichwillbemostpredominant.#X@XXX@#3g݌(#(# Ќ  "34"  3*2#  53  .3  0    X@XXX@Definethefollowingterms:_heterophile_Ԁantigen,_heterophile_Ԁantibody,_Forssman_Ԁantigen t and_Forssman_Ԁantibody.#X@XXX@#3*W݌`(#(# Ќ  "35"  382#  54  .3  0    X@XXX@StatetheprincipleofthePaul_Bunnell_Ԁscreeningtestforinfectiousmononucleosis#X@XXX@#X@XXX@.#X@XXX@t#38e݌L (#(# Ќ  "36"  32#  55  .3  0    X@XXX@Describetheprincipleofthe_Davidsohn_ԀDifferentialtestforinfectiousmononucleosis 8  includingtheclinicalsignificanceofresultsobtainedwiththesheep_RBCs_.#X@XXX@#3'݌$ t(#(# Ќ  "37"  32#  56  .3  0    X@XXX@State#X@XXX@#X@XXX@theprincipleofthemononucleosislatexagglutinationtest.#X@XXX@̟#3*݌ `(#(# Ќ  "38"  32#  57  .3  0    X@XXX@Describethetransmissionof_cytomegalovirus_.#X@XXX@#3݌ L (#(# Ќ  "39"  32#  58  .3  0    X@XXX@Describetheclinicalsymptomsof_cytomegalovirus_Ԁinfectionincludingpopulationsmost  8  atrisk.3݌$ (#(# Ќ  "3:"  3b2#  59  .3  0    Brieflylistlaboratorymethodsusedforthediagnosisof_cytomegalovirus_Ԁinfection.#X@XXX@m#X@XXX@3b݌ (#(# Ќ  "3;"  32#  60  .3  0    #X@XXX@#X@XXX@State#X@XXX@#X@XXX@thesubstancewhichisdetectedinapositivepregnancytest.#X@XXX@ԥ#3݌ (#(# Ќ  "3<"  32#  61  .3  0    Statetheamountoftimeasampleusedforapregnancytestmaybeusedifstoredatroom   temperaturecomparedtoasamplestoredintherefrigerator.3æ݌ (#(# Ќ  "3="  3 2#  62  .3  0    X@XXX@State#X@XXX@#X@XXX@Ԁtheprincipleofthefollowingtypesofpregnancytests:latexagglutinationand p monoclonalantibody(_ELISA_)test#X@XXX@٨#3 7݌\(#(# Ќ  "3>"  32#  63  .3  0    X@XXX@Listfour(4)diseasesorconditionsOTHERthanpregnancywhichmayresultina H positivepregnancytest.#X@XXX@#31݌4(#(# Ќ  "3?"  32#  64  .3  0    X@XXX@StatethecausativeagentofLymesDisease.#X@XXX@#3݌ p(#(# Ќ  "3@"  3Ǭ2#  65  .3  0    X@XXX@NamethevectorresponsiblefortransmissionofLymesdisease.#X@XXX@N#3Ǭ݌ \(#(# Ќ  "3A"  32#  66  .3  0    X@XXX@Statethelengthoftime#X@XXX@#X@XXX@thevectorofLymesdiseasemustremainattachedfor H transmissionofthediseasetooccur.#X@XXX@#3B݌4(#(# Ќ  "3B"  32#  67  .3  0    X@XXX@ListanddescribethreestagesofLymesDisease.#X@XXX@u#3݌ (#(# Ќ  "3C"  3.2#  68  .3  0    X@XXX@ListthethreetypesoftestscommonlyperformedteststoassistinthediagnosisofLymes   diseaseandindicatewhichoneismostsensitive.#X@XXX@#3.[݌(#(# Ќ  "3D"  3޲2#  69  .3  0    X@XXX@Statethefunctionandclinicalsignificanceof_haptoglobin_.#X@XXX@e#3޲ ݌(#(# Ќ  "3E"  3F2#  70  .3  0    X@XXX@Statethenormalvaluesfor_haptoglobin_.#X@XXX@ʹ#3Fs݌(#(# Ќ  "3F"  32#  71  .3  0    X@XXX@CompareandcontrastinfectionsduetoHSV1andHSV2#X@XXX@!#.3ǵ݌l(#(# Ќ  "3G"  3۶2#  72  .3  0    X@XXX@BrieflyliststhelaboratorytestmethodsusedtodiagnoseHSV1andHSV2.#X@XXX@b#3۶݌X (#(# Ќ  "3H"  302#  73  .3  0    X@XXX@Listtheorganismsresponsibleforandgiveabriefdescriptionofchickenpoxand D! shingles.#X@XXX@#30]݌0" (#(# Ќ  "3I"  32#  74  .3  0    X@XXX@Listthelaboratorytestsutilizedtodetectinfectionsduetochickenpoxandshingles.#X@XXX@3#3ٹ݌#l!(#(# Ќ  "3J"  32#  75  .3  0    X@XXX@StatethediseasecausedbytheRubellavirusandlistthesymptomsofthedisease.#X@XXX@#3=݌$X"(#(# Ќ  "3K"  3o2#  76  .3  0    X@XXX@Describetheconditionknownas congenitalrubella.#X@XXX@#3o݌$D #(#(# Ќ  "3L"  32#  77  .3  0    X@XXX@List3laboratorymethodologiesutilizedtodetectrubellaantibodies.#X@XXX@=#3݌%0!$(#(# Ќ  "3M"  32#  78  .3  0    X@XXX@Statethediseasecausedbytherubeolavirusandlistthesymptomsofthedisease.#X@XXX@#35݌&"%(#(# Ќ  "3N"  3g2#  79  .3  0    X@XXX@Intestingforrubeolastatetheantibodyclassismostfrequentlylookedforandexplain '#& thesignificance.#X@XXX@#3g݌(#'(#(# Ќ  "3O"  32#  80  .3  0    X@XXX@Listthreemethodologiesutilizedtodetectrubeolaantibodies.#X@XXX@y#3݌)$((#(# Ќ  "3P"  3=2#  81  .3  0    X@XXX@Listthesignsandsymptomsofmumps.#X@XXX@#3=j݌|*%)(#(# Ќ  "3Q"  3n2#  82  .3  0    X@XXX@Statethesignificanceof_IgM_Ԁand_IgG_Ԁantibody_titers_Ԁduringamumpsinfection#X@XXX@#.3n݌h+&*(#(# Ќ  "3R"  3)2#  83  .3  0    X@XXX@Statetherouteoftransmissionforthefivetypesofhepatitisviruses.#X@XXX@#3)V݌(#(# Ќ  "3S"  3}2#  84  .3  0    X@XXX@StatethehepatitisviruswhichrequiresaninfectionwithHepatitisBinorderforinfection  tooccur.#X@XXX@#3}݌(#(# Ќ  "3T"  32#  85  .3  0    X@XXX@Statethesignificanceofpresenceof_IgM_Ԁversus_IgG_Ԁclasshepatitisantibodiesin t determiningthestatusoftheinfectionofsomeonewithhepatitis.#X@XXX@#31݌`(#(# Ќ  "3U"  32#  86  .3  0    X@XXX@ForhepatitisB,listthreemarkersusedfordiagnosisandthesignificanceofeachone.#X@XXX@#3&݌L (#(# Ќ  "3V"  3]2#  87  .3  0    X@XXX@StatetheetiologicagentofAcquiredImmunodeficiencySyndrome(AIDS).#X@XXX@#3]݌8 (#(# Ќ  "3W"  32#  88  .3  0    X@XXX@ListthethreemainstructuralgenesofHIV.#X@XXX@7#3݌$ t(#(# Ќ  "3X"  32#  89  .3  0    X@XXX@StatefourmethodsoftransmissionofHIV.#X@XXX@o#3݌ `(#(# Ќ  "3Y"  32#  90  .3  0    X@XXX@ListanddescribethestagesofanHIVinfectionINCLUDINGpertinentlaboratoryresults  L  ofeach,_ie_,antibodypresence,CD4count,etc.#X@XXX@#3K݌ 8 (#(# Ќ  "3Z"  32#  91  .3  0    X@XXX@BRIEFLYdescribethefollowingmethods:#X@XXX@l#3݌$ (#(# Ќ   (#3 3[>__"; "  ;0  2#  j  .3  0` (#(#  X@XXX@_Turbidimetry_#X@XXX@X#X@XXX@;݌ ` (#` (# Ќ  "; "  ;(0  2#  k  .3  0` (#(#  #X@XXX@#X@XXX@_Nephelometry_#X@XXX@#X@XXX@;(U݌ ` (#` (# Ќ  "; "  ;0  2#  l  .3  0` (#(#  #X@XXX@S#X@XXX@Electrophoresis#X@XXX@r#X@XXX@;݌ ` (#` (# Ќ  "; "  ;%0  2#  m  .3  0` (#(#  #X@XXX@#X@XXX@Immunoelectrophoresis#X@XXX@#X@XXX@;%R݌p` (#` (# Ќ  "; "  ;0  2#  n  .3  0` (#(#  #X@XXX@9#X@XXX@_Immunofixation_Ԁelectrophoresis#X@XXX@X#X@XXX@;݌\` (#` (# Ќ  ";"  ;:0  2#  o  .3  0` (#(#  #X@XXX@#X@XXX@_Radioimmunoassay_#X@XXX@#X@XXX@;:g݌H` (#` (# Ќ  ";"  ;0  2#  p  .3  0` (#(#  #X@XXX@i#X@XXX@_Immunoradiometric_Ԁassay(IRMA)#X@XXX@#X@XXX@;݌4` (#` (# Ќ  ";"  ;j0  2#  q  .3  0` (#(#  #X@XXX@#X@XXX@Enzyme_Immunoassay_Ԁ(_ELISA_)#X@XXX@'#X@XXX@;j݌ p` (#` (# Ќ  ";"  ;%0  2#  r  .3  0` (#(#  #X@XXX@#X@XXX@Fluorescent_Immunoassay_Ԁ#X@XXX@#X@XXX@;%R݌ \` (#` (# Ќ  ";"  ;0  2#  s  .3  0` (#(#  #X@XXX@\#X@XXX@FluorescentPolarization#X@XXX@{#X@XXX@;݌H` (#` (# Ќ  ";"  ;70  2#  t  .3  0` (#(#  #X@XXX@#X@XXX@Chemiluminescent_Immunoassay_#X@XXX@#X@XXX@;7d݌4` (#` (# Ќ  ";"  ;0  2#  u  .3  0` (#(#  #X@XXX@r#X@XXX@NucleicAcidProbe#X@XXX@#X@XXX@;݌ ` (#` (# Ќ  ";"  ;G0  2#  v  .3  0` (#(#  #X@XXX@#X@XXX@HybridizationTechniques#X@XXX@#X@XXX@;Gt݌ ` (#` (# Ќ  ";"  ;0  2#  w  .3  0` (#(#  #X@XXX@^#X@XXX@Dotblot;݌` (#` (# Ќ  ""  0  0` (#(#2#  i  .3  0 ` (#` (#  Sandwichhybridization݌ (# (# Ќ  ""  0  0` (#(#2#  ii  .3  0 ` (#` (#  Southernblot݌ (# (# Ќ  ""  0  0` (#(#2#  iii  .3  0 ` (#` (#  Northernblot݌l (# (# Ќ  ""  0  0` (#(#2#  iv  .3  0 ` (#` (#  Solutionhybridization݌X  (# (# Ќ  ""  0  0` (#(#2#  v  .3  0 ` (#` (#  Insituhybridization"݌D! (# (# Ќ  ""  0  0` (#(#2#  vi  .3  0 ` (#` (#  DNA_Microarray_(݌0"  (# (# Ќ  ";"  ;0  2#  x  .3  0` (#(#  #X@XXX@}#X@XXX@Targetamplification;H݌#l!` (#` (# Ќ  ""  N0  0` (#(#2#  i  .3  0 ` (#` (#  ݀PolymeraseChainReaction(PCR)N{݌$X" (# (# Ќ  ""  _0  0` (#(#2#  ii  .3  0 ` (#` (#  _Ligase_ԀChainreaction#X@XXX@#X@XXX@_݌$D # (# (# Ќ  #X@XXX@f#X@XXX@#X@XXX@#X@XXX@#X@XXX@.#